Trial NCT01208441

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02487
Secondary IDs: 8554 CDR0000683397 NCI-2011-02487 U01CA099168 UPCI 09-080 UPCI-09-080

Last trial update was posted on 2013-09-30

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide Letrozole

MeSH Conditions

Breast Neoplasms

Other Conditions

Estrogen Receptor-positive Breast Cancer HER2-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID